Why the study?
Does adiponectin reduce myocardial ischemia/reperfusion injury in high-fat diet-induced diabetic mice?
Does adiponectin reduce myocardial ischemia/reperfusion injury in high-fat diet-induced diabetic mice?
High-fat diet-induced diabetes diminishes both AMPK-dependent and AMPK-independent adiponectin cardioprotection, suggesting adiponectin resistance in the diabetic heart.
Answers are grounded in this paper and cite their sources.
Adiponectin resistance may limit cardioprotection in diabetic hearts; leaves open whether resistance can be overcome in translational studies.
Diabetes exacerbates ischemic heart disease morbidity and mortality via incompletely understood mechanisms. Although adiponectin (APN) reduces myocardial ischemia/reperfusion (MI/R) injury in nondiabetic animals, whether APN's cardioprotective actions are altered in diabetes, a pathologic condition with endogenously reduced APN, has never been investigated. High-fat diet (HD)-induced diabetic mice and normal diet (ND) controls were subjected to MI via coronary artery ligation, and given vehicle or APN globular domain (gAPN, 2 μg/g) 10 min before reperfusion. Compared to ND mice (where gAPN exerted pronounced cardioprotection), HD mice manifested greater MI/R injury, and a tripled gAPN dose was requisite to achieve cardioprotective extent seen in ND mice (i.e., infarct size, apoptosis, and cardiac function). APN reduces MI/R injury via AMP-activated protein kinase (AMPK)-dependent metabolic regulation and AMPK-independent antioxidative/antinitrative pathways. Compared to ND, HD mice manifested significantly blunted gAPN-induced AMPK activation, basally and after MI/R (p<0.05). Although both low- and high-dose gAPN equally attenuated MI/R-induced oxidative stress (i.e., NADPH oxidase expression and superoxide production) and nitrative stress (i.e., inducible nitric oxide synthase expression, nitric oxide production, and peroxynitrite formation) in ND mice, only high-dose gAPN efficaciously did so in HD mice. We demonstrate for the first time that HD-induced diabetes diminished both AMPK-dependent and AMPK-independent APN cardioprotection, suggesting an unreported diabetic heart APN resistance.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: